project id: TCGA-LIHC; case submitter id: TCGA-KR-A7K2; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.96; rna integrity number: 7.3; age at index: 64; days to birth: -23699; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23699; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 829.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8180/3; primary diagnosis: Combined hepatocellular carcinoma and cholangiocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 85; initial weight: 70.0; oct embedded: false; preservation method: Unknown; sample id: 97843db5-32bd-4b54-8397-d5315d0922ec; sample submitter id: TCGA-KR-A7K2-01A; portion id: 7fe0cf36-4110-4962-948a-a173918265cf; portion submitter id: TCGA-KR-A7K2-01A-12; slide id: f0c361fc-cb5f-47af-99c5-ead83ea5465c; slide submitter id: TCGA-KR-A7K2-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;